+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
Cancer Biomarkers Market - Trends and Forecast Till 2035 - Product Thumbnail Image

Cancer Biomarkers Market - Trends and Forecast Till 2035

  • Report
  • October 2026
  • 336 Pages
  • Global
From
Digital Marketing Trends in Hepatocellular Carcinoma - Product Thumbnail Image

Digital Marketing Trends in Hepatocellular Carcinoma

  • Report
  • September 2022
  • 30 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Alzheimer's Drugs Market Report 2026 - Product Thumbnail Image

Alzheimer's Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market Report 2026 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator